Our recent investigations revealed a higher frequency of MBL deficiency-associated genotypes (LXA/O or O/O) among multiple myeloma (MM), but not lymphoma (LYMPH) or acute myeloid leukaemia (AML) patients, compared with controls [49,98]. The gene discussed is MBL2; the disease is plasma cell myeloma.